Patent Law Weblog
Month: May 2007
-
American Conference Institute (ACI) will be holding its Technology IP Due Diligence conference on June 21-22, 2007 in San Francisco, CA. The conference will provide the tools for evaluating the strengths and weakness of an IP portfolio, protecting a company's investments through effective due diligence reviews, and overcoming problems uncovered in due diligence. In particular,…
-
American Conference Institute (ACI) will be holding its Pharma/Biotech Patent Boot Camp on June 21-22, 2007 in New York, NY. The conference will focus on critical intellectual property and regulatory aspects of pharmaceutical and biotechnology patents, including Patent Office practice and claims drafting, FDA regulation and Hatch-Waxman Act exclusivity, product life cycles, freedom to operate…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Monsanto Company et. al. v. Stoffer1:07-cv-01438; filed May 16, 2007 in the Northern District of Ohio Infringement of U.S. Patent Nos. 5,352,605…
-
May 22, 2007 – "KSR International v. Teleflex: Supreme Court Radically Changes Test for Obviousness" (Strafford CLE Teleconferences) May 30, 2007 – "Patent Law After KSR v. Teleflex: Are Your Patents Still Valid?" (ABA CLE) May 31, 2007 – "Biotechnology and the Law: A Primer" – Part I (ABA CLE) June 7, 2007 – "Biotechnology…
-
By Kevin E. Noonan — The economic and political realities (both at home and abroad) are beginning to be felt with regard to intellectual property protections for Western companies in poor and developing nations, as evidenced by changes to American trade policies announced recently (see "Worldwide Drug Pricing Regime in Chaos"). Specifically, the…
-
By Christopher P. Singer — As previously reported on Patent Docs, the John Marshall Law School hosted an IPLAC panel discussion relating to the Supreme Court’s recent decision in KSR Int’l Co. v. Teleflex Inc. The discussion was moderated by Edward D. Manzo, and panelists included Chief Judge James F. Holderman and Judge…
-
By Jason Derry — Siena Biotech S.p.A. has announced that it has entered a collaboration agreement with Roche relating to discovery and development of treatments for neurodegenerative diseases. Under the Agreement, Roche and Siena Biotech will engage in joint research activities involving screening and generating compounds, modeling and drug design, compound optimization, and…
-
By Kevin E. Noonan — James Surowiecki, who writes a weekly column called "The Financial Page" in The New Yorker magazine and is the author of "The Wisdom of Crowds," doesn’t like patents. He complained about business method patents in his column in the July 14, 2003 edition of the magazine (see "Patent…
-
By Kevin E. Noonan — The Supreme Court’s recent KSR Int’l Co. v. Teleflex Inc. decision is stunning in the amount of dicta it contains (and confusing dicta at that). The Court succumbed to imprecise language (albeit not quite gobbledygook) even when addressing the merits of the case, particularly its reasoning for reversing…
-
By Kevin E. Noonan — Lost in the reaction to KSR Int’l Co. v. Teleflex Inc. two weeks ago was the Court’s decision in Microsoft Corp. v. AT&T Corp., rendered on the same day. While not directed to a biotechnology invention, the case has interesting implications for the relationship between activities overseas and…
Patent Docs 